等待开盘 05-12 09:30:00 美东时间
+0.035
+1.92%
Compass Therapeutics (NASDAQ:CMPX) reported quarterly losses of $(0.10) per share which met the analyst consensus estimate. This is a 16.67 percent increase over losses of $(0.12) per share from the same period last
05-05 19:52
Compass Therapeutics will participate in a fireside chat at the Jefferies Global Healthcare Conference on June 5, 2025, from 11:05 to 11:35 AM ET. More details and a webcast link are available.
2025-05-28 12:00
Ladenburg Thalmann analyst Aydin Huseynov upgrades Compass Therapeutics (NASDAQ:CMPX) from Neutral to Buy and announces $5 price target.
2024-09-16 21:26